Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
Primary Purpose
Multiple Sclerosis
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Wellness Patient Message
Sponsored by
About this trial
This is an interventional treatment trial for Multiple Sclerosis
Eligibility Criteria
Inclusion Criteria:
- Age 18-89 years of age
- Diagnosis of MS (G35) seen at the Johns Hopkins MS Precision Medicine Center of Excellence within the past year, and upcoming appointment within the three-month window. We will require the relevant ICD10 code to be documented at least twice in two separate visits, either in the problem list and/or visit diagnosis, in order to avoid misdiagnosis.
- MyChart active account
- Provides consent to complete questionnaires and undergo randomization
Exclusion Criteria:
- Patients known to be deceased in Epic
- Patients who have opted out of being contacted for research recruitment
- Patients who have opted out of being contacted for MyChart recruitment
- Patients who have opted out of being contacted for any reason
Sites / Locations
- Johns Hopkins Outpatient CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Wellness Smartphrase
No Intervention
Arm Description
This arm will receive a secure message after the conclusion of their standard clinic visit providing a set script containing information on a number of wellness-related topics in MS (sleep, diet, exercise).
This arm will not receive a secure message after their appointment, and will instead receive their standard care with their provider.
Outcomes
Primary Outcome Measures
Change in self-efficacy as assessed by the MS Self-Efficacy Scale (MSSE)
Patients will take the MS Self-Efficacy Scale (MSSE), which has a score range 90-900, with higher scores reflecting greater sense of self-efficacy
Secondary Outcome Measures
Change in Sleep Disturbance the Neuro-Quality of Life Sleep disturbance short form
Patient-reported outcomes on the Neuro-Quality of Life Sleep disturbance short form, which has a score range of 8-40, with higher scores reflecting better quality of sleep.
Change in Diet behavior Scores as assessed by the Mediterranean-DASH Intervention for Neurodegenerative Delay score (MIND Diet score)
Patient-reported behaviors on diet through the Mediterranean-DASH Intervention for Neurodegenerative Delay score (MIND Diet score), which has a score range of 0-15, with higher scores reflecting a higher, healthier, quality of diet.
Change in Reported physical activity as assessed by the Godin Leisure-Time Exercise Questionnaire (GLTEQ)
Patient-reported behaviors on physical activity through the Godin Leisure-Time Exercise Questionnaire (GLTEQ). The score range is from 0-119, with higher scores reflecting a greater degree of physical exercise.
Change in Reported physical activity as assessed by the International Physical Activity Questionnaire (IPAQ) short form
Patient-reported behaviors on physical activity through the International Physical Activity Questionnaire (IPAQ) short form. Results are reported in metabolic minutes (MET-min), and are continuous, with range of 0-200,000 per week, and higher scores indicating greater physical activity.
Full Information
NCT ID
NCT05442112
First Posted
June 28, 2022
Last Updated
October 5, 2023
Sponsor
Johns Hopkins University
1. Study Identification
Unique Protocol Identification Number
NCT05442112
Brief Title
Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
Official Title
A Randomized Control Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 11, 2023 (Actual)
Primary Completion Date
April 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this project, the investigators hope to evaluate effective methods of communication with patients with multiple sclerosis regarding habits of physical activity, sleep, and diet. Currently, there is weak evidence regarding how to deliver adequate information at scale in the clinics with respect to diet, exercise, and sleep. It is unclear if receiving structured information impacts patient-reported outcomes in multiple sclerosis (MS).
The study team hopes to evaluate the efficacy of after visit direct patient messaging in promoting any behavioral changes, the sustainability of those behavioral changes, and most importantly, if those changes impact patient-reported sense of self-efficacy in the participants disease management. In addition, the study team hopes that the data collected during this study will provide answers on how providing wellness strategies impacts patient reported outcomes, markers of behavior, and sense of disease progression.
Detailed Description
This will be a prospective randomized control trial assessing the impact of the delivery of wellness-related information on patient-reported outcomes in multiple sclerosis. The investigators plan to query all patients who meet inclusion criteria over the course of at least three consecutive months who will be seen at the Johns Hopkins Outpatient Center Multiple Sclerosis clinic. On average, 200 patients are seen in the MS clinic monthly, and the investigators hope to enroll 120 patients in this time period. If the investigators are unable to reach this target number in two months, the investigators will continue to message patients over consecutive months until the investigators reach this number. The study team will send a recruitment message through MyChart to all eligible patients prior to the patients next clinic appointment to participate in the study, after which the patients will be consented (with documentation of waiver of consent) if interested. Those who are interested will be asked to fill out a series of electronic baseline questionnaires prior to the patient's appointment (sent by REDCap using subject-specific links).
Participants will subsequently be randomized 1:1 (stratified within each provider's daily clinic schedule) to either receive a secure message providing a set script (see Supplementary Materials) containing information on a number of wellness-related topics in MS (sleep, diet, exercise), or to receiving no additional information other than that provided by the participants clinician. This message will be sent as a secure message through Epic by a member of the study team by the end of the clinic day.
At one month and three months after the clinic visit, the study team will send the same questionnaires as were sent at baseline, assessing self-efficacy, reported physical activity, dietary habits, and sleep quality through REDCap subject-specific links.
The investigators will assess for any differences in outcomes between the control group and the group who received the wellness-related secure message. The investigators will evaluate for covariates that were imbalanced and adjust models when imbalance did occur, which is plausible given the expected sample size. In addition, the investigators will also evaluate via chart review whether diet, exercise, and sleep were assessed or discussed during the clinic visit.
In addition, the investigators will use descriptive statistics to describe participants and compare those who agree versus those who do not agree to participate. The investigators hope to evaluate density of use of the electronic medical record amongst this cohort, as well as demographic data on social determinants of health, including race, socioeconomic status, and geographic location, in order to evaluate predictors of responsiveness to the messaging.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized 1:1 within provider schedules to either receive a secure message containing a set script on wellness-related topics in MS, or no additional information other than that provided by their clinician.
Masking
ParticipantCare Provider
Masking Description
Participants will not know which arm they are assigned to, and neither will their provider.
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Wellness Smartphrase
Arm Type
Experimental
Arm Description
This arm will receive a secure message after the conclusion of their standard clinic visit providing a set script containing information on a number of wellness-related topics in MS (sleep, diet, exercise).
Arm Title
No Intervention
Arm Type
No Intervention
Arm Description
This arm will not receive a secure message after their appointment, and will instead receive their standard care with their provider.
Intervention Type
Behavioral
Intervention Name(s)
Wellness Patient Message
Intervention Description
The intervention is a detailed patient message containing information on strategies for exercise in MS, how to maintain proper sleep, and dietary improvements to maximize health. These strategies are derived from information provided by the National MS Society in their website and covers these topics in greater detail than would normally be addressed in a normal clinic visit. The message also directs patients to the National MS Society website if they would like more information.
Primary Outcome Measure Information:
Title
Change in self-efficacy as assessed by the MS Self-Efficacy Scale (MSSE)
Description
Patients will take the MS Self-Efficacy Scale (MSSE), which has a score range 90-900, with higher scores reflecting greater sense of self-efficacy
Time Frame
Baseline, 1 month, 3 months
Secondary Outcome Measure Information:
Title
Change in Sleep Disturbance the Neuro-Quality of Life Sleep disturbance short form
Description
Patient-reported outcomes on the Neuro-Quality of Life Sleep disturbance short form, which has a score range of 8-40, with higher scores reflecting better quality of sleep.
Time Frame
Baseline, 1 month, 3 months
Title
Change in Diet behavior Scores as assessed by the Mediterranean-DASH Intervention for Neurodegenerative Delay score (MIND Diet score)
Description
Patient-reported behaviors on diet through the Mediterranean-DASH Intervention for Neurodegenerative Delay score (MIND Diet score), which has a score range of 0-15, with higher scores reflecting a higher, healthier, quality of diet.
Time Frame
Baseline, 1 month, 3 months
Title
Change in Reported physical activity as assessed by the Godin Leisure-Time Exercise Questionnaire (GLTEQ)
Description
Patient-reported behaviors on physical activity through the Godin Leisure-Time Exercise Questionnaire (GLTEQ). The score range is from 0-119, with higher scores reflecting a greater degree of physical exercise.
Time Frame
Baseline, 1 month, 3 month
Title
Change in Reported physical activity as assessed by the International Physical Activity Questionnaire (IPAQ) short form
Description
Patient-reported behaviors on physical activity through the International Physical Activity Questionnaire (IPAQ) short form. Results are reported in metabolic minutes (MET-min), and are continuous, with range of 0-200,000 per week, and higher scores indicating greater physical activity.
Time Frame
Baseline, 1 month, 3 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18-89 years of age
Diagnosis of MS (G35) seen at the Johns Hopkins MS Precision Medicine Center of Excellence within the past year, and upcoming appointment within the three-month window. We will require the relevant ICD10 code to be documented at least twice in two separate visits, either in the problem list and/or visit diagnosis, in order to avoid misdiagnosis.
MyChart active account
Provides consent to complete questionnaires and undergo randomization
Exclusion Criteria:
Patients known to be deceased in Epic
Patients who have opted out of being contacted for research recruitment
Patients who have opted out of being contacted for MyChart recruitment
Patients who have opted out of being contacted for any reason
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shuvro Roy, MD
Phone
937-838-2428
Email
sroy33@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Ellen Mowry, MD
Email
emowry1@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shuvro Roy, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Ellen Mowry, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Scott Newsome, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Peter Calabresi, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Shiv Saidha, MBBCh
Organizational Affiliation
Johns Hopkins University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Pavan Bhargava, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Michael Kornberg, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Study Director
Facility Information:
Facility Name
Johns Hopkins Outpatient Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21287
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shuvro Roy, MD
Phone
937-838-2428
Email
sroy33@jh.edu
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to share individual participant data
Citations:
PubMed Identifier
28080254
Citation
Motl RW, Mowry EM, Ehde DM, LaRocca NG, Smith KE, Costello K, Shinto L, Ng AV, Sullivan AB, Giesser B, McCully KK, Fernhall B, Bishop M, Plow M, Casaccia P, Chiaravalloti ND. Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities. Mult Scler. 2018 Mar;24(3):262-267. doi: 10.1177/1352458516687404. Epub 2017 Jan 12.
Results Reference
background
PubMed Identifier
19085318
Citation
Motl RW, McAuley E, Snook EM, Gliottoni RC. Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychol Health Med. 2009 Jan;14(1):111-24. doi: 10.1080/13548500802241902.
Results Reference
background
Learn more about this trial
Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
We'll reach out to this number within 24 hrs